Flexible Endoscopic Surgery Robot Market Size - By Category, By Application, By End Use & Global Forecast, 2025 - 2034

Flexible Endoscopic Surgery Robot Market Size

The global flexible endoscopic surgery robot market was valued at USD 974.3 million in 2024. The market is expected to reach from USD 1.1 billion in 2025 to USD 4.1 billion in 2034, growing at a CAGR of 15.6% during the forecast period, according to the latest report published by Global Market Insights Inc. Growing requirements for minimally invasive surgical instrument, innovations in robotics technology, and increasing surgical volumes are fueling the market growth.

The worldwide flexible endoscopic surgery robot market provides cutting-edge surgical solutions to hospitals, ambulatory surgical centers, and healthcare providers, facilitating minimally invasive surgery, accuracy, and better patient outcomes. Offerings include flexible robotic systems for gastrointestinal, urological, gynecological, and pulmonary procedures with AI, imaging, and robotic support for diagnostics and therapeutics. Leaders like Intuitive Surgical, Medtronic, CMR Surgical, Asensus Surgical, and Medrobotics stay competitive by offering constant innovation, strategic alliances, international growth, and high R&D spend, meeting growing demands for technology-enabled safe and efficient minimally invasive procedures.
 

The market has increased from USD 671.6 million in 2021 and reached USD 855.8 million in 2023. The flexible endoscopic surgery robot market is witnessing significant growth, driven by multiple interrelated factors. A major driver is the increasing preference for minimally invasive surgical procedures, which offer patients reduced postoperative pain, shorter hospital stays, faster recovery times, and minimal scarring compared to conventional open surgeries. Hospitals and surgical centers are increasingly adopting robotic-assisted platforms to enhance precision, dexterity, and control during complex endoscopic procedures, particularly in gastrointestinal, urological, gynecological, and pulmonary interventions.
 

Technological advancements in robotics, including AI integration, high-definition imaging, and flexible robotic arms, are enabling surgeons to perform intricate procedures with greater accuracy, reducing the risk of complications and improving overall patient outcomes. Additionally, the rising volume of surgical procedures globally, fueled by an aging population and increasing prevalence of chronic conditions requiring surgical intervention, is further propelling market demand. Strategic initiatives by key market players, including continuous R&D, innovative product launches, and global expansion, enhance accessibility and adoption of these robotic systems across healthcare facilities. Moreover, growing awareness among healthcare professionals about the benefits of robotic-assisted endoscopy and supportive reimbursement frameworks in key regions are acting as additional catalysts, collectively driving the market’s rapid growth during the forecast period.
 

A flexible endoscopic surgery robot is a robotic-assisted medical device designed to perform minimally invasive procedures with enhanced precision, dexterity, and control. It combines flexible robotic arms, AI, and high-definition imaging to enable surgeons to access complex anatomical regions, improving patient outcomes, reducing recovery time, and minimizing surgical risks.
 

Flexible Endoscopic Surgery Robot Market Trends

The worldwide flexible endoscopic surgery robot industry is largely driven by the escalating demand for minimally invasive procedures. Surgeons and patients increasingly look for surgical options that provide less postoperative pain, shorter hospital stays, quicker recovery, and minimal scarring.
 

• Minimally invasive surgery (MIS) offers these advantages without sacrificing surgical effectiveness, and therefore it is the procedure of choice for surgeons and patients alike. This change of preference among patients and physicians is a key motivator for the use of flexible endoscopic surgical robots, which are designed to enable complicated procedures in cramped anatomical regions with utmost precision.
   
• Technological innovations are directly related to this trend. Advances like flexible robotic arms, high-definition 3D imaging, real-time AI-guided direction, and improved ergonomic design enhance the dexterity and precision of surgeons while operating. These advancements not only enhance the rate of procedure success but also decrease the likelihood of complications, which further supports the embracement of minimally invasive practices. Interoperability with AI enables predictive analytics, intraoperative decision support, and enhanced visualization, making flexible endoscopic robots invaluable tools in contemporary surgery.
   
• From a macroeconomic perspective, rising healthcare expenditure, increasing hospital infrastructure investments, and favorable government initiatives supporting advanced surgical technologies enhance market growth. The global prevalence of chronic diseases, including gastrointestinal, urological, and gynecological disorders, further increases the demand for MIS, as robotic-assisted procedures are increasingly applied to manage these conditions.
   
• At the microeconomic level, hospitals and surgical centers are investing in advanced robotic platforms to differentiate their services, attract patients, and improve operational efficiency. Competitive pressures among healthcare providers, combined with patient demand for minimally invasive options, encourage the adoption of flexible endoscopic robots.
   
• As a result, the market continues to grow, driven by the convergence of patient preference, technological innovation, and favorable economic conditions, positioning minimally invasive procedures as a central growth driver for the flexible endoscopic surgery robot.
   

Flexible Endoscopic Surgery Robot Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market for flexible endoscopic surgery robot was valued at USD 671.6 million in 2021. The market size reached USD 855.8 million in 2023, from USD 756 million in 2022.
 

Based on the category, the market is segmented into therapeutic and diagnostic. The therapeutic segment accounted for over 58.2% market share in 2024, driven by rising adoption of minimally invasive procedures, improved precision control, and growing demand for complex surgical interventions. The segment is expected to exceed USD 2.5 billion by 2034, growing at a CAGR of 16% during the forecast period.
 

On the other hand, the diagnostic segment is expected to grow with a CAGR of 15.1% through 2034. The growth of this segment can be attributed to increasing screening programs, technological advancements in visualization, and early disease detection through robotic-assisted endoscopy.
 

• The therapeutic segment is led chiefly by the growing use of robotic-assisted minimally invasive procedures for advanced therapeutic interventions. These platforms provide high-precision navigation, increased dexterity, and improved visualization, permitting surgeons to conduct sophisticated interventions like tumor resections, polypectomies, and submucosal dissections with reduced trauma.
   
• The combination of 3D imaging, AI-driven motion control, and haptic feedback technologies has greatly enhanced surgical success, shortening procedure time and hospital stays.
   
• Increasing need for minimally invasive treatments in gastroenterology, urology, and pulmonology also increases adoption further. Additionally, rising R&D expenditures by major players to create flexible and multifunctional robotic systems have increased the therapeutic usage of endoscopic robotics.
   
• The global trend toward outpatient and ambulatory surgery centers performing complex therapeutic procedures also supports market growth. Overall, the therapeutic segment benefits from continuous technological advancements, expanding indications, and the growing emphasis on patient safety and recovery optimization.
   
• The diagnostic segment held a revenue of USD 407.3 million in 2024, with projections indicating a steady expansion at 15.1% CAGR from 2025 to 2034. The diagnostic segment is driven by the growing need for early and accurate disease detection, particularly for gastrointestinal and pulmonary conditions. Flexible robotic endoscopes enhance diagnostic precision by providing superior maneuverability and high-definition visualization of complex anatomical regions that are difficult to access with conventional endoscopy.
   
• The increasing prevalence of colorectal cancer, inflammatory bowel diseases, and lung disorders has elevated the demand for advanced robotic systems capable of performing detailed and minimally invasive diagnostics.
   
• Integration of imaging modalities such as optical coherence tomography (OCT) and AI-assisted lesion detection further enhances diagnostic accuracy. Hospitals and specialty clinics are adopting these systems to reduce false negatives and improve patient outcomes through early detection.
   
• Furthermore, the rising shift toward disposable robotic endoscopes minimizes cross-contamination risks, driving safer diagnostic practices. Continuous innovation by companies in robotic diagnostic systems supports greater procedural efficiency and patient comfort, strengthening the segment’s growth trajectory.
   

Based on application, the flexible endoscopic surgery robot market is classified into urology, respiratory applications, gastrointestinal applications, and other applications. The urology segment dominated the market with a revenue share of 41.3% in 2024 and is expected to reach USD 1.7 billion by 2034.
 

• The urology area is motivated by the rising rate of urological conditions like kidney stones, prostate cancer, and urinary tract blockages. The rising use of minimally invasive robotic-assisted surgeries for operations like nephrectomy, prostatectomy, and cystectomy has greatly improved accuracy, lowered surgical trauma, and curtailed recovery periods.
   
• Furthermore, ongoing technological improvements like greater flexible robotic arms and AI-based navigation systems are making endoscopic interventions more precise.
   
• The respiratory applications segment exceeded USD 300.2 million in 2024, with projections indicating a steady expansion at 16.2% CAGR from 2025 to 2034. The respiratory applications segment is witnessing steady growth, primarily driven by the increasing incidence of lung cancer, chronic obstructive pulmonary disease (COPD), and other airway disorders. Flexible endoscopic surgical robots are transforming bronchoscopy procedures by offering superior navigation, enhanced precision, and improved access to distal lung regions.
   
• These robotic systems enable minimally invasive interventions such as bronchoscopic biopsies and ablations, reducing the need for open thoracic surgeries.
   
• The gastrointestinal applications segment crossed USD 205.6 million in 2024, with projections indicating a steady expansion at 14.5% CAGR from 2025 to 2034. The gastrointestinal (GI) applications segment is experiencing robust growth, fueled by the rising prevalence of gastrointestinal cancers, colorectal polyps, and peptic ulcers.
   
• Flexible endoscopic surgical robots are increasingly used for diagnostic and therapeutic procedures such as endoscopic submucosal dissection (ESD), colonoscopy, and gastroscopy, offering improved maneuverability and accuracy within the complex anatomy of the digestive tract.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the flexible endoscopic surgery robot market is classified into hospital & clinics, ambulatory surgical centers, and other end users. The hospital & clinics segment dominated the market with a revenue share of 64.2% in 2024 and is expected to reach USD 2.7 billion by 2034.
 

• The two largest segments account for over 92.6% of the total market value. Hospitals & clinics segment accounts for the largest market share of the flexible endoscopic surgery robot market, owing to the growing usage of sophisticated robotic-assisted systems for demanding gastrointestinal, colorectal, and thoracic surgeries.
   
• Big hospitals have the resources and facilities required to incorporate robotic endoscopy platforms, which provide better visualization, accuracy, and control for minimally invasive procedures.
   
• Additionally, increased incidence of gastrointestinal diseases like colorectal cancer and inflammatory bowel disease has encouraged hospitals to implement flexible robotic systems that reduce recovery time and trauma due to surgery.
   
• These facilities benefit from dedicated surgical teams, specialized endoscopy units, and robust reimbursement frameworks that encourage investment in advanced robotic technologies.
   
• The ambulatory surgical centers segment held a revenue of USD 276.7 million in 2024, with projections indicating a steady expansion at 15.2% CAGR from 2025 to 2034. The ambulatory surgical centers (ASCs) segment is witnessing rapid growth due to the increasing shift of outpatient procedures from hospitals to cost-effective, specialized facilities. ASCs offer flexible scheduling, shorter procedure times, and reduced hospitalization costs, making them ideal for minimally invasive robotic-assisted endoscopic interventions.
   
• The miniaturization of robotic systems and advancements in flexible endoscopes have made these technologies suitable for outpatient settings, driving adoption among ASCs.
   
• Additionally, favorable reimbursement policies and the growing emphasis on value-based care encourage physicians to perform diagnostic and therapeutic endoscopic procedures in ASCs.

Looking for region specific data?

Download Free PDF

North America dominated the global flexible endoscopic surgery robot market with the highest market share of 35.5% in 2024.
 

• The region is blessed with the presence of major market players like Intuitive Surgical, Medtronic, and Johnson & Johnson that always invest in R&D and training initiatives. Rising incidence of gastrointestinal and colorectal diseases, along with a large number of minimally invasive surgical procedures being performed, complements the increasing adoption of flexible robotic platforms among hospitals and ambulatory surgery centers.
   
• Supportive reimbursement policies and regulatory backing from the FDA drive clinical adoption of robotic endoscopy systems. In addition, strong investments in medical innovation, increasing demand for outpatient procedures, and increasing awareness of the value of precision-based, minimally invasive procedures continue to bolster market growth.
   

The U.S. flexible endoscopic surgery robot market was valued at USD 230.8 million and USD 257.6 million in 2021 and 2022, respectively. In 2024, the market size grew to USD 326.4 million from USD 289.1 million in 2023.
 

• The U.S. leads the North American flexible endoscopic surgery robot industry, driven by high healthcare spending, advanced hospital infrastructure, and early technological adoption. The U.S. market benefits from a strong ecosystem of robotics manufacturers, research institutions, and clinical partnerships that accelerate innovation and commercialization.
   
• Increasing incidence of gastrointestinal cancers and chronic digestive disorders has boosted demand for minimally invasive, robot-assisted endoscopic procedures offering faster recovery and reduced complications.
   
• The Centers for Medicare & Medicaid Services (CMS) reimbursement policies favoring robotic-assisted surgeries further promote adoption across hospitals and ambulatory surgical centers.
   
• Additionally, rising investments in AI-integrated robotic platforms, surgeon training initiatives, and FDA approvals for next-generation systems like Johnson & Johnson’s MONARCH platform contribute significantly to market expansion.
   

Europe flexible endoscopic surgery robot market size crossed USD 268.5 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The Europe market is witnessing robust growth driven by the increasing demand for minimally invasive procedures, advanced healthcare infrastructure, and strong governmental support for medical innovation.
   
• The rising incidence of gastrointestinal, colorectal, and urological disorders has accelerated the adoption of flexible robotic systems that enable precise, scar-free, and faster recovery surgeries. Leading healthcare institutions across countries such as the UK, France, and Italy are rapidly integrating robotic platforms into endoscopy suites to enhance surgical accuracy and patient outcomes.
   
• Favorable reimbursement frameworks and investments in surgical robotics research, supported by initiatives like Horizon Europe, further boost adoption. Moreover, the presence of key industry players, continuous product innovation, and surgeon training programs across Europe are driving the clinical acceptance of flexible robotic systems.
   

Germany dominates the European flexible endoscopic surgery robot market, showcasing strong growth potential, supported by its technologically advanced healthcare ecosystem, early adoption of robotic-assisted systems, and strong manufacturing base for medical technologies.
 

• The country’s robust network of university hospitals and specialized endoscopy centers drives clinical adoption through continuous innovation and research in minimally invasive robotic procedures. Rising cases of gastrointestinal and thoracic conditions, combined with an aging population seeking less invasive surgical options, are fueling demand.
   
• Furthermore, Germany’s favorable reimbursement policies and well-established healthcare infrastructure support the integration of flexible robotic platforms in both public and private hospitals.
   
• German manufacturers and research institutions are actively collaborating on next-generation robotic solutions featuring enhanced flexibility, AI-guided navigation, and improved ergonomics.
   

The Asia Pacific flexible endoscopic surgery robot market is anticipated to grow at the highest CAGR of 16.8% during the analysis timeframe.
 

• The Asia Pacific region is driven by rapid healthcare infrastructure development, increasing demand for minimally invasive procedures, and growing adoption of robotic-assisted surgical technologies. Rising incidences of gastrointestinal and colorectal disorders, coupled with a growing geriatric population, are propelling the need for advanced diagnostic and therapeutic endoscopic solutions.
   
• Government initiatives promoting medical innovation, coupled with favorable reimbursement policies in countries such as Japan, South Korea, and Australia, are supporting market expansion.
   
• Furthermore, collaborations between regional hospitals and global medical device manufacturers are enhancing access to cutting-edge robotic systems. Increasing investments in healthcare digitization, surgeon training, and AI-integrated endoscopy technologies also contribute to market growth.
   

China flexible endoscopic surgery robot market is estimated to grow with a significant CAGR in the Asia Pacific region.
 

• China represents one of the most dynamic markets for flexible endoscopic surgery robots, fueled by government-led initiatives to advance robotic surgery and medical device innovation. The growing prevalence of gastrointestinal cancers, rising awareness of minimally invasive procedures, and expansion of specialized endoscopy centers are key growth drivers.
   
• Substantial R&D investments and supportive regulatory reforms under the Made in China 2025 initiative have encouraged domestic production of advanced robotic systems, reducing dependence on imports. Moreover, partnerships between leading hospitals and technology firms are accelerating the adoption of flexible robotic platforms in both diagnostic and therapeutic applications.
   
• Increasing healthcare expenditure, a large patient base, and the government’s focus on digital and precision medicine are further driving growth.
   

Brazil leads the Latin American flexible endoscopic surgery robot industry, exhibiting remarkable growth during the analysis period, due to its rapid advancements in healthcare infrastructure, growing investments in minimally invasive surgical technologies, and rising adoption of robotic-assisted systems in tertiary hospitals.
 

• The country’s expanding network of private healthcare providers and medical tourism industry further supports the integration of advanced endoscopic robotics to improve surgical outcomes and patient safety.
   
• Increasing cases of gastrointestinal cancers, obesity-related disorders, and colorectal conditions are driving the demand for precise and less invasive procedures. Moreover, government initiatives promoting the digital transformation of hospitals and collaborations with global medical device manufacturers are enhancing technology transfer and surgeon training programs.
   

Saudi Arabia flexible endoscopic surgery robot industry is expected to experience substantial growth in the Middle East and Africa in 2024, driven by strong government support under the Saudi Vision 2030 initiative to modernize healthcare infrastructure and integrate advanced medical technologies. The increasing prevalence of gastrointestinal and bariatric conditions, coupled with a rising preference for minimally invasive and robotic-assisted procedures, fuels market demand.
 

• Major public and private hospitals are investing heavily in robotic platforms to improve precision, reduce complications, and enhance patient recovery times. Additionally, Saudi Arabia is witnessing growing collaborations with international robotic surgery companies to establish local training centers and technology partnerships, strengthening domestic capabilities.
   
• The emphasis on enhancing surgical efficiency, reducing hospital stays, and improving patient outcomes aligns with national goals of advancing healthcare quality.
   

Flexible Endoscopic Surgery Robot Market Share

The global flexible endoscopic surgery robot industry is highly competitive, with major medical device manufacturers focusing on technological innovation, AI integration, and strategic alliances to strengthen their market foothold. Increasing demand for minimally invasive surgeries, growing prevalence of gastrointestinal and colorectal disorders, and advancements in robotic-assisted systems are driving companies to enhance precision, flexibility, and surgical efficiency. The market is also benefiting from the global shift toward outpatient and same-day procedures, supporting adoption across hospitals and ambulatory surgical centers.
 

Key players such as Intuitive Surgical, Medtronic, CMR Surgical, Asensus Surgical, and Medrobotics collectively account for 79.1% of the global market share. These companies maintain leadership through strong R&D pipelines, versatile product portfolios, and partnerships with healthcare institutions for clinical integration and training. Their focus on improving haptic feedback, visualization, and autonomous control is redefining procedural capabilities.
 

Emerging and niche players are increasingly entering the market with compact, cost-effective robotic systems designed for flexible endoscopy applications. Competitive differentiation now centers on system miniaturization, enhanced maneuverability, and cross-specialty compatibility. As the market evolves, competition is expected to intensify with a strong emphasis on AI-enabled navigation, real-time imaging, and interoperability with digital surgical ecosystems, positioning robotics as a cornerstone of next-generation minimally invasive care.
 

Flexible Endoscopic Surgery Robot Market Companies

A few of the prominent players operating in the flexible endoscopic surgery robot industry include:
 

• Asensus Surgical
• CMR Surgical
• Endo Tools Therapeutics
• Endotics
• GI View
• Intuitive Surgical
• Johnson & Johnson
• Medrobotics
• Medtronic
  
   
•  Intuitive Surgical

Intuitive Surgical leads the flexible endoscopic surgery robot market with a share of 34.3% in 2024. Intuitive Surgical’s unique selling proposition lies in its da Vinci SP system, which offers unparalleled precision, 3D visualization, and single-port flexibility for complex endoluminal and minimally invasive procedures. Its advanced robotic articulation, intuitive surgeon console, and extensive clinical validation make it the global leader in flexible robotic-assisted surgery.
 

•  Medtronic

Medtronic’s Hugo Robotic-Assisted Surgery (RAS) system stands out for its modular, portable design and seamless integration with advanced visualization and data analytics tools. It enables enhanced flexibility, cost efficiency, and connectivity for minimally invasive procedures, making it a highly scalable and accessible solution in the flexible endoscopic surgery robot market.
 

Flexible Endoscopic Surgery Robot Industry News:

• In May 2025, Olympus Corporation (Japan) received FDA 510(k) clearance for its EZ1500 series endoscopes, featuring Extended Depth of Field (EDOF) technology to improve visualization accuracy and diagnostic performance.
   
• In January 2025, KARL STORZ SE & Co. KG (Germany) completed the strategic acquisition of its long-term Swiss distributor, ANKLIN, to enhance its direct sales network in Switzerland. This acquisition strengthened customer engagement and optimized customized product and service delivery across the MedTech sector.
   
• In January 2024, Olympus Corporation (Japan) acquired Taewoong Medical Co., Ltd., a Korea-based medical device manufacturer. This acquisition expanded Olympus’s GI Endo Therapy product portfolio, enhanced its ability to deliver integrated clinical solutions, and advanced patient care standards through improved treatment outcomes.
   

The flexible endoscopic surgery robot market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Category

• Therapeutic
• Diagnostic

Market, By Application

• Urology
• Respiratory applications
• Gastrointestinal applications
• Other applications

Market, By End Use

• Hospital & clinics
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE